N-terminal phosphorylation of glutaminase C decreases its enzymatic activity and cancer cell migration.

Abstract The mitochondrial phosphate-activated glutaminase C (GAC) is produced by the alternative splicing of the GLS gene. Compared to the other GLS isoform, the kidney-type glutaminase (KGA), GAC is more enzymatically efficient and of particular importance for cancer cell growth. Although its catalytic mechanism is well understood, little is known about how post-translational modifications can impact GAC function. Here, we identified by mass spectrometry a phosphorylated serine at the GLS N-terminal domain (at position 95) and investigated its role on regulating GAC activity. The ectopic expression of the phosphomimetic mutant (GAC.S95D) in breast cancer cells, compared to wild-type GAC (GAC.WT), led to decreased glutaminase activity, glutamine uptake, glutamate release and intracellular glutamate levels, without changing GAC sub-cellular localization. Interestingly, cells expressing the GAC.S95D mutant, compared to GAC.WT, presented decreased migration and vimentin level, an epithelial-to-mesenchymal transition marker. These results reveal that GAC is post-translationally regulated by phosphorylation, which affects cellular glutamine metabolism and glutaminase-related cell phenotype. Graphical abstract Image 1 Highlights • We identified by mass spectrometry a phosphorylation site in the serine 95 of human glutaminase C (GAC) expressed in breast cancer cells. • The mutant GAC.S95D has diminished glutaminase activity. • Cells expressing GAC.S95D have decreased glutaminase activity, glutamine uptake, glutamate secretion and intracellular glutamate levels. • Cells expressing GAC.S95D presented reduction on vimentin and migration. [ABSTRACT FROM AUTHOR]